TMS (transcranial magnetic stimulation) is a noninvasive brain stimulation treatment that uses magnetic pulses to activate nerve cells in specific areas of the brain. It’s most commonly used for depression that hasn’t responded to antidepressant medication. The FDA first cleared TMS for major depressive disorder in 2008, and it has since become a mainstream option for people who need an alternative to medication.
How TMS Works
A TMS device contains a magnetic coil that sits against your scalp. When activated, the coil generates a brief, high-intensity magnetic field pulse that passes through your skull and induces small electric currents in brain tissue. These currents are strong enough to activate neurons directly, essentially “waking up” areas of the brain that are underactive in depression.
The standard target is the left dorsolateral prefrontal cortex, a region involved in mood regulation that tends to show reduced activity in people with depression. Repeated stimulation over multiple sessions triggers the brain to release dopamine and serotonin, two chemical messengers closely tied to mood. The dopamine release from a single TMS session is comparable to what you’d see from a low dose of a stimulant medication. Over weeks of treatment, these repeated activations appear to reshape neural connections through the same mechanisms your brain uses to form new memories and learn new skills.
What a Treatment Session Looks Like
Your first visit is longer than the rest because it includes a calibration step called motor threshold mapping. The technician places the coil over the part of your brain that controls hand movement and delivers test pulses at gradually increasing intensity until your thumb or fingers twitch about half the time. This tells the clinician exactly how much magnetic energy your brain needs to respond, and it’s used to set your treatment intensity for all future sessions.
Once your threshold is set, the coil is repositioned over the left prefrontal cortex and treatment begins. You sit in a chair (similar to a dentist’s chair), fully awake, with no anesthesia or sedation. You’ll hear a clicking or tapping sound and feel a knocking sensation on your scalp with each pulse. Sessions run five days a week for four to six weeks, with a typical course totaling 30 to 36 sessions. A taper phase of about three weeks follows, during which sessions gradually decrease in frequency.
Standard vs. Theta Burst Protocols
The original FDA-cleared protocol, called high-frequency rTMS, takes about 37.5 minutes per session. A newer protocol called intermittent theta burst stimulation (iTBS) delivers the same 600 pulses in just over 3 minutes. The FDA cleared iTBS in 2018, and studies comparing the two show nearly identical results: response rates of about 48% for iTBS versus 46% for standard rTMS, and remission rates of 30% versus 25%. The shorter session time makes iTBS far more practical for people with work or family schedules that can’t accommodate a 40-minute daily appointment.
Success Rates for Depression
In clinical trials involving patients with treatment-resistant depression (most of whom had already failed two or more antidepressant medications), roughly half experienced a meaningful improvement in symptoms. About 27% to 32% achieved full remission, meaning their depression scores dropped to levels considered healthy. These numbers are notable because these patients had already tried and failed standard treatments.
Response doesn’t happen overnight. Most people begin noticing changes somewhere around the second or third week of treatment, though some respond earlier or later. The effects can be durable for months after completing a course, and “maintenance” sessions (periodic single treatments) are sometimes used to sustain the benefit.
Side Effects and Safety
TMS has a mild side effect profile compared to antidepressant medications. There’s no systemic drug circulating through your body, so you won’t experience weight gain, sexual dysfunction, or drowsiness. The most common complaints are headache (reported by roughly 7% of patients) and discomfort at the stimulation site on the scalp (about 3%). Both tend to be mild and often decrease over the first few sessions as you get used to the sensation.
The most serious risk is seizure, but the incidence is extremely low. A survey covering more than 586,000 treatment sessions and over 25,000 patients found just 18 seizures total, a rate of about 0.03 per 1,000 sessions. That makes the seizure risk from TMS comparable to or lower than the seizure risk associated with many antidepressant medications.
Who Should Not Have TMS
The main contraindication is metal in or near the head. Cochlear implants are particularly problematic because TMS can damage their electronic components, demagnetize the internal magnet, or induce dangerous voltages in the implant’s antenna. Intracranial metal implants, surgical skull plates, and aneurysm clips near the stimulation area are also disqualifying. Standard dental fillings and braces are generally fine because they’re far enough from the coil. People with a history of epilepsy or seizure disorders aren’t automatically excluded, but they require extra precautions and careful screening.
Insurance Coverage and Eligibility
Most insurance plans, including Medicare, cover TMS for major depressive disorder, but you typically need to meet specific criteria first. Under Medicare’s coverage policy, you must have a confirmed diagnosis of severe major depressive disorder and have failed at least one antidepressant medication taken at an adequate dose for an adequate duration. “Failure” can also mean intolerable side effects that aren’t expected to resolve with continued use. Many private insurers follow similar requirements, though some require documentation of two or more failed medication trials before approving TMS. Coverage is generally limited to six weeks of acute treatment.
Out-of-pocket costs without insurance vary widely but often fall in the range of $6,000 to $12,000 for a full course. With insurance, copays depend on your specific plan. It’s worth calling your insurer before starting treatment to confirm what documentation your provider will need to submit for prior authorization.
What TMS Does Not Treat
While TMS is FDA-cleared for major depressive disorder, researchers are actively studying its use in obsessive-compulsive disorder, PTSD, anxiety disorders, and chronic pain. Some clinics offer TMS for these conditions as off-label use, but the strongest evidence by far remains in depression. If you’re considering TMS for something other than depression, ask specifically about the evidence base for your condition and whether your insurance will cover an off-label application (most won’t).